
Sign up to save your podcasts
Or


Interview with Jordan L. Schultz, PharmD, author of β-Blocker Use and Delayed Onset and Progression of Huntington Disease. Hosted by Cynthia E. Armand, MD.
Related Content:
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Interview with Marja A. Boermeester, MD, PhD, and Charlotte L. Van Veldhuisen, MD, authors of Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis: Follow-Up Analysis of the ESCAPE Randomized Clinical Trial. Hosted by Amalia Cochran, MD.
Related Content:
Interview with Chloe I. Bloom, BSc, MSc, PhD, author of Antidiabetic Medication and Asthma Attacks, and Katherine N. Cahill, MD, author of Borrowing From the Type 2 Diabetes Armamentarium for Asthma. Hosted by Eve Rittenberg, MD.
Related Content:
Interview with Robbi A. Kupfer, MD, Nadine I. Ibrahim, MD, and Janice L. Farlow, MD, PhD, authors of Peripartum and Pregnancy-Related Considerations in Residency. Hosted by Paul C. Bryson, MD MBA.
Related Content:
Interview with Daniel T. Myran, MD, MPH, author of Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder. Hosted by John Torous, MD.
Related Content:
Interview with Barry A. Borlaug, MD, and Jwan A. Naser, MBBS, authors of Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation. Hosted by James E. Udelson, MD.
Related Content:
Interview with Giovanni B. Frisoni, MD, author of Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation. Hosted by Cynthia E. Armand, MD.
Related Content:
Interview with Benoit H. Mulsant, MD, MS, and Tarek K. Rajji, MD, authors of Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial. Hosted by John Torous, MD, MBI.
Related Content:
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:

136 Listeners

318 Listeners

698 Listeners

498 Listeners

36 Listeners

103 Listeners

291 Listeners

3,353 Listeners

38 Listeners

13 Listeners

16 Listeners

22 Listeners

6 Listeners

1,157 Listeners

29 Listeners

196 Listeners

92 Listeners

520 Listeners

372 Listeners

430 Listeners

17 Listeners

374 Listeners

59 Listeners